(Q46872875)

26 December 2017

title

Effect of pravastatin on plasma sterols and oxysterols in men. (English)

1 reference

26 December 2017

author

Juhani Knuuti

5

1 reference

26 December 2017

Terho Lehtimäki

7

Terho Lehtimäki

1 reference

26 December 2017

4

Tuula Janatuinen

1 reference

26 December 2017

Reijo Laaksonen

8

Reijo Laaksonen

1 reference

26 December 2017

Risto Vesalainen

3

Risto Vesalainen

1 reference

26 December 2017

Karin M Thelen

1

Karin M Thelen

1 reference

26 December 2017

Klaus von Bergmann

6

Klaus von Bergmann

1 reference

26 December 2017

Dieter Lütjohann

2

Dieter Lütjohann

1 reference

26 December 2017

publication date

30 December 2005

1 reference

26 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

26 December 2017

volume

62

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

9-14

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00228-005-0068-9

exact match

0 references

cites work

Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-005-0068-9

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-005-0068-9

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

21 January 2018

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease

1 reference

12 December 2020

Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo

1 reference

12 December 2020

Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects.

1 reference

12 December 2020

Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.

1 reference

12 December 2020

Statins and the risk of dementia

1 reference

12 December 2020

Effects of lovastatin and chenodiol on bile acid synthesis, bile lipid composition, and biliary lipid secretion in healthy human subjects

1 reference

12 December 2020

Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

12 December 2020

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

1 reference

12 December 2020

cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain

1 reference

12 December 2020

Power and sample size calculations for studies involving linear regression

1 reference

12 December 2020

Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

1 reference

12 December 2020

The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.

1 reference

12 December 2020

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

1 reference

12 December 2020

Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients

1 reference

12 December 2020

Cholesterol metabolism in the brain

1 reference

12 December 2020

Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation

1 reference

12 December 2020

Brain cholesterol: long secret life behind a barrier.

1 reference

12 December 2020

Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis

1 reference

12 December 2020

Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

A potential role for sterol 27-hydroxylase in atherogenesis.

1 reference

12 December 2020

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

12 December 2020

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol

1 reference

12 December 2020

Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro.

1 reference

12 December 2020

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

1 reference

12 December 2020

High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial

1 reference

12 December 2020

Beneficial cardiovascular pleiotropic effects of statins

1 reference

12 December 2020

Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases.

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man

1 reference

12 December 2020

From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans

1 reference

12 December 2020

Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans

1 reference

12 December 2020

Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain

1 reference

12 December 2020

Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase

1 reference

12 December 2020

10.1007/S00228-005-0068-9

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017